|
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma |
|
|
|
Titel: |
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma |
Auteur: |
Ren, Zhenggang Shao, Guoliang Shen, Jie Zhang, Li Zhu, Xu Fang, Weijia Sun, Guoping Bai, Yuxian Wu, Jianbing Liu, Lianxin Yuan, Yuan Zhang, Jingdong Li, Zhen Zhang, Ling Yin, Tao Wu, Jincai Hou, Xiaoli Yu, Haoyu Li, Jing Wang, Qingyu Zhu, Jun Fan, Jia , |
Verschenen in: |
Cancer, immunology, immunotherapy |
Paginering: |
Jaargang 74 () nr. 2 pagina's xx |
Jaar: |
2025-01-03 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|